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doi: 10.1016/j.bpj.2011.06.004Many of the nutrients that a cell needs for its functioning,
such as sugars, amino acids, nucleotides, or organic bases,
require specialized transporters to cross the cell membrane
(1–3). The rapid growth of available information character-
ized as ‘‘transporter explosion’’ by Uhl and Hartig (4), has
led to creation of the transporter classification system,
with division of all transporters into channels and carriers.
Channel proteins are mainly considered to function as
selective pores which do not need conformational rearrange-
ments at each substrate translocation event. Their optimiza-
tion principles were addressed in several recent articles (see
e.g., (5–9)). This Letter is focused on optimization of
carrier-facilitated transport. A carrier transfers substrates
via a mechanism that includes at least four steps: i), Binding
of the substrate to the carrier on one side of the membrane;
ii), carrier conformational change leading to substrate tran-
sition to the other side; iii), dissociation of the substrate, and
iv), return of the carrier to its initial conformation/position
in the membrane (1–3).
The diagram describing these steps of transport in the
case of a passive uniporter carrier is shown in Fig. 1.
In the human genome there are 43 distinct families of
transport systems that comprise >300 isoforms of indi-
vidual solute carriers (10). Although the majority of these
transport systems is responsible for uptake of specific
substrates, a substantial number of transporters are used
for uptake of the same solute, and often have an overlapping
expression of multiple isoforms that exists in the same cell
type. So, the naturally arising question (see, e.g., (11)) is:
Why are there so many transporter isoforms?
Here we offer a possible answer by analyzing the carrier-
facilitated transport described by the kinetic scheme in
Fig. 1 (see also (12,13)) with the focus on the optimal
efficiency of the transporter. Analytical expressions are
derived for the optimal values of i), the dissociation rate
constant, and ii), the ratio of the forward and backward ratesof the carrier conformational transitions, which maximize
the flux.
We demonstrate that at lower substrate concentrations
stronger substrate binding is required, and that the devia-
tions from optimal interaction become more critical as the
substrate concentration increases, i.e., higher concentrations
necessitate more precise tuning. Thus, uniporters designed
to transport the same molecule in the same cell have to be
optimized with different amino-acid sequences, with one
gene coding for a uniporter protein that functions most effi-
ciently at high solute concentrations, whereas another gene
is coding for the one that is most efficient at low concentra-
tions. Although quantitative analysis of optimization of
carrier-facilitated transport was conducted almost 30 years
ago for the liquid membranes of extraction technology
(14), to the best of our knowledge it has never been applied
to biological carriers.
Usually it is assumed that the flux of the substrate mole-
cules across the membrane is controlled by the conforma-
tional dynamics of the transporter. This implies fast
equilibration between loaded ES and unloaded E states of
the transporter on both sides of the membrane. We relax
this assumption and consider loading and unloading of the
transporter and its conformational dynamics on an
equal footing. Consider a membrane containing N trans-
porters assuming that C
ð2Þ
S ¼ 0. Let the number of trans-
porters in each of the four states (see Fig. 1) at time t
be N
ð1Þ
E ðtÞ, Nð2ÞE ðtÞ, Nð1ÞES ðtÞ, and Nð2ÞES ðtÞ, respectively, i.e.,
N
ð1Þ
E ðtÞ þ Nð2ÞE ðtÞ þ Nð1ÞES ðtÞ þ Nð2ÞES ðtÞ ¼ N. The rate equa-
tions determining variations of these numbers with time
are (see notations in Fig. 1)
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FIGURE 1 Schematic representation of the simplest model of
carrier-facilitated exchange of substrate molecules, S, between
sides 1 and 2 of the membrane (12,13). The model assumes
that the unloaded transporter jumps between the two conforma-
tions in which it can bind substrate molecules on sides 1 and 2, ,
with the jump rates a and b. Similar rates of the conformational
transitions of the ES-complex (loaded transporter),
ESð1Þ%ESð2Þ, are a0 and b0. Formation and dissociation of the
ES-complex, EDS%ES, are characterized by rate constants
kb and kd, which in general can be different on the two sides
of the membrane, where the substrate concentrations, respec-
tively, are C
ð1Þ
S and C
ð2Þ
S .
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FIGURE 2 Transporter efficiency as a function of normalized
dissociation constant kd /b, Eq. 3 with a ¼ b, for five values of
the normalized concentration, k
ð1Þ
b C
ð1Þ
S =b ¼ 0.0001, 0.003, 0.1, 1,
and 10, from top to bottom.
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ð1Þ
E ðtÞ
dt
¼ bNð2ÞE ðtÞ 

aþ kð1Þb Cð1ÞS

N
ð1Þ
E ðtÞ þ kð1Þd Nð1ÞES ðtÞ;
dN
ð1Þ
ES ðtÞ
dt
¼ kð1Þb Cð1ÞS Nð1ÞE ðtÞ 

a0 þ kð1Þd

N
ð1Þ
ES ðtÞ þ b0Nð2ÞES ðtÞ;
dN
ð2Þ
E ðtÞ
dt
¼ kð2Þd Nð2ÞES ðtÞ  bNð2ÞE ðtÞ þ aNð1ÞE ðtÞ;
dN
ð2Þ
ES ðtÞ
dt
¼ a0Nð1ÞES ðtÞ 

b0 þ kð2Þd

N
ð2Þ
ES ðtÞ: (1)
To demonstrate our major findings we limit ourselves to the
case when the rate constants of the conformational transi-
tions are independent of whether the transporter is loaded
or not, a ¼ a0, b ¼ b0, and the dissociation rate constants
on both sides of themembrane are the same, k
ð1Þ
d ¼ kð2Þd ¼ kd.
The maximum rate of substrate binding to the transporters
is achieved when N
ð1Þ
E ¼ N (i.e., all transporters are empty,
and they are on side 1 of the membrane). Using this rate,
k
ð1Þ
b C
ð1Þ
S N, as a scale, we can write the steady-state flux, J,
of the substrate molecules across the membrane as
J ¼ F

a; b; kdjkð1Þb Cð1ÞS

k
ð1Þ
b C
ð1Þ
S N; (2)where factor Fða; b; kdjkð1Þb Cð1ÞS Þ can be interpreted as the
transporter efficiency. The flux is a monotonic function of
the product k
ð1Þ
b C
ð1Þ
S , whereas it is nonmonotonic with re-
spect to kd,a, and b.With this inmind, we split the arguments
of the transporter efficiency into two groups separated by
a vertical line.
Solving Eq. 1 in steady-state, we can write the efficiency
in the form
F¼ ab
ðaþbÞ
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(3)
analysis of which shows that the efficiency reaches its
maximum at kd ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
bk
ð1Þ
b C
ð1Þ
S
q
. Interestingly enough, k*d
being proportional to
ﬃﬃﬃ
b
p
is independent of a. Fig. 2 presents
the transporter efficiency at equal jump rates, a ¼ b, as
a function of the normalized dissociation constant kd/b for
five values of the normalized concentration k
ð1Þ
b C
ð1Þ
S =b. In
similarity to our earlier results on optimization of channel-
facilitated transport (6), optimization of the carrier-facili-
tated transport at lower substrate concentrations requires
not only stronger substrate binding to the transporter
protein, but also is less sensitive to the tuning. Indeed, the
optimization curve for k
ð1Þ
b C
ð1Þ
S =b ¼ 0.0001 is much wider
than that for k
ð1Þ
b C
ð1Þ
S =b ¼ 0.1.
In the more general case, when a s b, function
Fða; b; kdjkð1Þb Cð1ÞS Þ optimized with respect to kd can be
further optimized with respect to the ratio of the conforma-
tional jump rates, n ¼ a/b,Biophysical Journal 101(2) L14–L16
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FIGURE 3 Transporter efficiency as a function of the ratio of
conformational jump rates n ¼ a/b, Eq. 4 for four values of the
normalized concentration, k
ð1Þ
b C
ð1Þ
S =b ¼ 0.0001, 0.1, 1, and 10,
from top to bottom.
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
a; b; kdjkð1Þb Cð1ÞS

¼ n
ð1þ nÞ

nþ

1þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
k
ð1Þ
b C
ð1Þ
S =b
q 2 :
(4)
This function is monotonic in b and nonmonotonic in n
as shown in Fig. 3. The function vanishes as n / 0 and
n/N and has a maximum in-between. The optimal value
of the jump rate ratio, n¼ n*, that maximizes the transporter
efficiency in Eq. 4 is
n ¼ 1þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
k
ð1Þ
b C
ð1Þ
S =b
q
: (5)
Thus, the optimal forward jump rate is always higher than
the backward jump rate, a* ¼ n* b > b. This agrees with
a number of experimental observations where such
a phenomenon is called ‘‘accelerated exchange’’ (15).
The transporter efficiency optimized with respect to both
kd and n is given by
F

a; b; kdjkð1Þb Cð1ÞS

¼ 1
2þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
k
ð1Þ
b C
ð1Þ
S =b
q 2: (6)
Respectively, the maximum flux of the substrate molecules
across the membrane containing N transporters is
Jmax ¼ k
ð1Þ
b C
ð1Þ
S N
2þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
k
ð1Þ
b C
ð1Þ
S =b
q 2: (7)
The optimized flux monotonically increases with b from
zero at b ¼ 0 to kð1Þb Cð1ÞS N=4 as b/ N. Respectively, the
optimized transporter efficiency, Eq. 6, increases from
zero to its maximum value 1/4. Qualitatively similar nonmo-
notonic behavior of the steady-state flux can be obtainedBiophysical Journal 101(2) L14–L16using different simplifying assumptions; for example, in
the case of symmetric transporter, b0 ¼ a0 and b ¼ a.
Thus, the results obtained above are of general nature.
The existence of multiple transporter isoforms that carry
the same molecule is well documented for almost any
important substrate (1–3,10,11). Although this variety of
isoforms may seem redundant and, in principle, could be ex-
plained by the lack of strong evolutionary pressures to
decrease the size of the genome, our analysis offers
a different possibility. We have demonstrated that trans-
porter efficiency is fine-tuned to specific ranges of substrate
concentration, so that different isoforms might be tailored
accordingly to adjust their amino-acid composition for the
optimal strength of substrate/transporter interactions and
the transition rates between different conformations.ACKNOWLEDGMENTS
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